Answered step by step
Verified Expert Solution
Question
1 Approved Answer
(1) Liquidity: Current Ratio FY2021 FY2022 Comments on Liquidity Ratios, What story do the numbers tell for Pfizer in comparison to its competitor Moderna? Pfizer
(1) Liquidity: | |||||||||||||||||||
Current Ratio | FY2021 | FY2022 | Comments on Liquidity Ratios, What story do the numbers tell for Pfizer in comparison to its competitor Moderna? | ||||||||||||||||
Pfizer | 1.3989 | 1.2165 | |||||||||||||||||
Moderna | 1.76 | 2.73 | |||||||||||||||||
Quick Ratio | FY2021 | FY2022 | |||||||||||||||||
Pfizer | 1.19 | 1 | |||||||||||||||||
Moderna | 1.6 | 2.54 | |||||||||||||||||
(2) Asset Management: | Comments on Asset Management ratios, What story do the numbers tell for Pfizer in comparison to its competitor Moderna? | ||||||||||||||||||
Total Asset Turnover | FY2021 | FY2022 | |||||||||||||||||
Pfizer | 0.4479 | 0.5088 | |||||||||||||||||
Moderna | 0.7488 | 0.745 | |||||||||||||||||
Avg. Collection Period | "Receivable Turnover ratio" | ||||||||||||||||||
Pfizer | 7.0815 | 9.1609 | |||||||||||||||||
Moderna | 13.9083 | 5.8176 | |||||||||||||||||
(3) Debt Management: | Comments on Debt Management ratios, What story do the numbers tell for Pfizer in comparison to its competitor Moderna? | ||||||||||||||||||
Total Debt to Total Assets | FY2021 | FY2022 | "debt equity ratio" | ||||||||||||||||
Pfizer | 0.4962 | 0.3735 | |||||||||||||||||
Moderna | 0.0423 | 0.0477 | |||||||||||||||||
Times Interest Earned | FY2021 | FY2022 | EBITDA/Interest Expense | ||||||||||||||||
Pfizer | 20.9x | 31.5x | |||||||||||||||||
Moderna | 782.1x | 324.8x | |||||||||||||||||
(4) Profitability: | Comments on Profitability ratios, What story do the numbers tell for Pfizer in comparison to its competitor Moderna? | ||||||||||||||||||
Net Profit Margin | FY2021 | FY2022 | |||||||||||||||||
Pfizer | 27.0384 | 31.2688 | |||||||||||||||||
Moderna | 66.0603 | 43.4097 | |||||||||||||||||
Return on Assets | FY2021 | FY2022 | |||||||||||||||||
Pfizer | 12.3757 | 15.923 | |||||||||||||||||
Moderna | 49.4629 | 32.3382 | |||||||||||||||||
Return on Equity | FY2021 | FY2022 | |||||||||||||||||
Pfizer | 28.9936 | 32.7377 | |||||||||||||||||
Moderna | 86.2637 | 43.7275 | |||||||||||||||||
Modified Du Pont Equation for FY22 | |||||||||||||||||||
Pfizer | Moderna | ||||||||||||||||||
Net Profit Margin | 31.27 | 43.41 | |||||||||||||||||
Total Asset Turnover | 0.5088 | 0.745 | |||||||||||||||||
Equity Multiplier | 2.06 | 1.35 | |||||||||||||||||
Market Value Ratios | Comments on Market Value ratios, What story do the numbers tell for Pfizer in comparison to its competitor Moderna? | ||||||||||||||||||
PE Ratio | FY2021 | FY2022 | |||||||||||||||||
Pfizer | 14.72 | 9.26 | |||||||||||||||||
Moderna | 8.98 | 8.93 | |||||||||||||||||
Market to Book Ratio | FY2021 | FY2022 | "Price to book ratio" | ||||||||||||||||
Pfizer | 4.11 | 2.97 | |||||||||||||||||
Moderna | 7.24 | 3.62 | |||||||||||||||||
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started